National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Send to Printer
NCI Drug Dictionary

recombinant fowlpox-CEA(6D)/TRICOM vaccine
A cancer vaccine comprised of a recombinant fowlpox virus vector encoding the carcinoembryonic antigen (CEA) and a TRIad of COstimulatory Molecules (B7-1, ICAM-1 and LFA-3) (TRICOM). This agent may enhance CEA presentation to antigen presenting cells (APC) and activate cytotoxic T-cells against CEA-expressing tumors. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:fowlpox-CEA-B7-1/ICAM-1/LFA-3
rF-CEA(6D)TRICOM

Previous:recombinant CD40-ligand, recombinant dHER2 vaccine, recombinant flt3 ligand, recombinant fowlpox GM-CSF vaccine adjuvant, recombinant fowlpox-B7.1 vaccine
Next:recombinant fowlpox-prostate apecific antigen vaccine, recombinant fowlpox-TRICOM vaccine, recombinant fowlpox-tyrosinase vaccine, recombinant human 6Ckine, recombinant human chorionic gonadotropin